23 October 2024 • 1 minute read
The Inflation Reduction Act Impacts on Pricing in the Life Sciences Industry
David Hamilton facilitates a conversation with Lisa LeCointe-Cephas, partner and co-chair of the Life Sciences sector at DLA Piper, Kirsten Axelsen, senior policy advisor at DLA Piper, and Celeste Saravia, vice president at Cornerstone Research, on the impacts of the Inflation Reduction Act on innovation, competition, and pricing in the life sciences industry.
